McMaster University Mar 30 2026 A major international trial suggests that a widely available antidepressant may help ease one of long COVID’s most disabling symptoms, bringing patients and clinicians closer to a practical treatment option. A global research team co-led by McMaster University has identified one of the first medications shown to meaningfully reduce fatigue in people living with long COVID – a breakthrough for millions still struggling with persistent symptoms years after the

Tag-uri: Coronavirus